DE798378T1 - Östrogen-Rezeptor - Google Patents

Östrogen-Rezeptor

Info

Publication number: DE798378T1
Authority: DE; Germany
Prior art keywords: estrogen receptor; receptors; relates; present; dna encoding
Prior art date: 1996-03-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

DE0798378T

Other languages

English (en)

Other versions

DE29700903U1 (de

Inventor

Sietse Mosselman

Rein Dijkema

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Akzo Nobel NV

Original Assignee

Akzo Nobel NV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-26

Filing date

1997-03-25

Publication date

1999-03-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26142641&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE798378(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-03-25 Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV

1999-03-04 Publication of DE798378T1 publication Critical patent/DE798378T1/de

Status Pending legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

DE0798378T 1996-03-26 1997-03-25 Östrogen-Rezeptor Pending DE798378T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP96200820		1996-03-26
EP96203284		1996-11-11

Publications (1)

Publication Number	Publication Date
DE798378T1 true DE798378T1 (de)	1999-03-04

Family

ID=26142641

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE69709561T Revoked DE69709561T2 (de)	1996-03-26	1997-03-25	Östrogen-Rezeptor
DE0798378T Pending DE798378T1 (de)	1996-03-26	1997-03-25	Östrogen-Rezeptor

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DE69709561T Revoked DE69709561T2 (de)	1996-03-26	1997-03-25	Östrogen-Rezeptor

Country Status (13)

Country	Link
US (3)	US7060490B1 (de)
EP (2)	EP1162264A3 (de)
JP (1)	JPH104986A (de)
KR (1)	KR19980041692A (de)
AT (1)	ATE212055T1 (de)
AU (1)	AU715812B2 (de)
CA (1)	CA2200423C (de)
DE (2)	DE69709561T2 (de)
DK (1)	DK0798378T3 (de)
ES (1)	ES2123482T3 (de)
GR (1)	GR980300076T1 (de)
HK (1)	HK1001978A1 (de)
HU (1)	HU221411B1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100263137B1 (ko)	1995-09-08	2000-08-01	오테스코그 페르	오판 수용체
US7157568B1 (en) *	1997-08-05	2007-01-02	American Home Products Corporation	Human estrogen receptor-β
EP1012177B1 (de) *	1997-09-08	2006-08-09	Merck & Co., Inc.	Östrogenrezeptor
US6222015B1 (en)	1997-09-08	2001-04-24	Merck & Co., Inc.	Estrogen receptor
DE19839115A1 (de) *	1998-08-27	2000-03-09	Ihf Inst Fuer Hormon Und Fortp	Klonierung und Expression von Rinder Estrogenrezeptor-beta
US7528123B1 (en)	1998-11-20	2009-05-05	N.V. Organon	Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11
DE19855013C2 (de) *	1998-11-20	2001-09-13	Schering Ag	Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element
ATE246703T1 (de) *	1999-04-06	2003-08-15	Akzo Nobel Nv	Oral wirksame 7-alpha-alkyl androgene
WO2001064665A1 (en)	2000-03-01	2001-09-07	Akzo Nobel N.V.	Chroman derivatives as estrogenic compounds
AU2001249315A1 (en)	2000-03-22	2001-10-03	Rheogene, Inc.	Ecdysone receptor-based inducible gene expression system
US20040033600A1 (en)	2001-03-21	2004-02-19	Palli Subba Reddy	Ecdysone receptor-based inducible gene expression system
TWI225068B (en)	2000-06-06	2004-12-11	Akzo Nobel Nv	Anellated steroid compounds having contraceptive and anti-osteoporosis activity
US8105825B2 (en)	2000-10-03	2012-01-31	Intrexon Corporation	Multiple inducible gene regulation system
CA2441444C (en)	2001-02-20	2013-09-03	Rheogene Holdings, Inc.	Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system
CA2438133C (en)	2001-02-20	2015-01-27	Rheogene, Inc.	Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
JP4955905B2 (ja)	2001-02-20	2012-06-20	イントレキソンコーポレーション	キメラレチノイドｘ受容体および新規エクジソン受容体−ベースの誘導性遺伝子発現システムにおけるそれらの使用
CA2445796C (en)	2001-02-20	2014-09-16	Rheogene, Inc.	Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
EP1288303A1 (de) *	2001-08-23	2003-03-05	Aventis Pharma S.A.	Induzierbare Expressionssysteme unter Verwendung von PPAR Transkriptionsaktivatoren
WO2003012113A2 (en) *	2001-08-02	2003-02-13	Gencell S.A.	Inducible expression systems employing ppar transcriptional activators
JP2005532781A (ja)	2001-09-26	2005-11-04	レオジーン・ホールディングス，インコーポレーテッド	ヨコバイエクジソン受容体核酸、ポリペプチド、およびそれらの使用
AU2002327787A1 (en) *	2001-09-28	2003-04-07	Gordon L. Hager	Glucocorticoid receptor nuclear translocation domain
TW200304371A (en)	2002-02-22	2003-10-01	Akzo Nobel Nv	Substituted 10-ary1-11H-benzo [b] fluorenes and 7-ary1-5, 6-dihydro-benz [a] anthracenes for selective effects on estrogen receptors
US7674783B2 (en)	2002-11-22	2010-03-09	Dimera Inc.	Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease
US7304161B2 (en)	2003-02-10	2007-12-04	Intrexon Corporation	Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7456315B2 (en)	2003-02-28	2008-11-25	Intrexon Corporation	Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7935510B2 (en)	2004-04-30	2011-05-03	Intrexon Corporation	Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
UA89964C2 (ru)	2004-09-08	2010-03-25	Н.В. Органон	15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
SG11201506875YA (en)	2013-03-15	2015-09-29	Intrexon Corp	Boron-containing diacylhydrazines
EP3194359B1 (de)	2014-09-17	2020-04-08	Intrexon Corporation	Borhaltige diacylhydrazinverbindungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1987005049A1 (en) *	1986-02-20	1987-08-27	California Biotechnology Inc.	Eucaryotic expression of steroid receptor proteins
US5217867A (en) *	1988-11-30	1993-06-08	The Salk Institute For Biological Studies	Receptors: their identification, characterization, preparation and use
FR2649994A1 (fr) *	1989-06-30	1991-01-25	Aderegem	Procede d'obtention d'un recepteur humain natif sauvage des oestrogenes et ses applications
WO1992008133A1 (en) *	1990-10-29	1992-05-14	Dekalb Plant Genetics	Isolation of biological materials using magnetic particles
EP0609240B1 (de) *	1991-09-17	2002-04-03	The Salk Institute For Biological Studies	Rezeptoren der steroid/thyroid superfamilie von rezeptoren
KR100263137B1 (ko) *	1995-09-08	2000-08-01	오테스코그 페르	오판 수용체
US7157568B1 (en) *	1997-08-05	2007-01-02	American Home Products Corporation	Human estrogen receptor-β

1997
- 1997-03-19 CA CA002200423A patent/CA2200423C/en not_active Expired - Fee Related
- 1997-03-24 HU HU9700636A patent/HU221411B1/hu not_active IP Right Cessation
- 1997-03-25 EP EP01202021A patent/EP1162264A3/de not_active Withdrawn
- 1997-03-25 AU AU16521/97A patent/AU715812B2/en not_active Ceased
- 1997-03-25 EP EP97200903A patent/EP0798378B1/de not_active Revoked
- 1997-03-25 DE DE69709561T patent/DE69709561T2/de not_active Revoked
- 1997-03-25 DE DE0798378T patent/DE798378T1/de active Pending
- 1997-03-25 ES ES97200903T patent/ES2123482T3/es not_active Expired - Lifetime
- 1997-03-25 DK DK97200903T patent/DK0798378T3/da active
- 1997-03-25 KR KR1019970010207A patent/KR19980041692A/ko not_active Application Discontinuation
- 1997-03-25 AT AT97200903T patent/ATE212055T1/de not_active IP Right Cessation
- 1997-03-26 US US08/826,361 patent/US7060490B1/en not_active Expired - Fee Related
- 1997-03-26 JP JP9074122A patent/JPH104986A/ja not_active Withdrawn
1998
- 1998-02-11 HK HK98101021A patent/HK1001978A1/xx not_active IP Right Cessation
- 1998-11-30 GR GR980300076T patent/GR980300076T1/el unknown
2000
- 2000-06-30 US US09/608,088 patent/US6680368B1/en not_active Expired - Lifetime
- 2000-11-13 US US09/711,288 patent/US6713270B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1162264A3 (de)	2002-05-15
HU9700636D0 (en)	1997-05-28
US6713270B1 (en)	2004-03-30
GR980300076T1 (en)	1998-11-30
DK0798378T3 (da)	2002-04-29
ATE212055T1 (de)	2002-02-15
AU715812B2 (en)	2000-02-10
HUP9700636A3 (en)	1999-01-28
DE69709561D1 (de)	2002-02-21
EP0798378A3 (de)	1997-12-29
HU221411B1 (en)	2002-09-28
KR19980041692A (ko)	1998-08-17
US7060490B1 (en)	2006-06-13
EP0798378A2 (de)	1997-10-01
AU1652197A (en)	1997-10-02
US6680368B1 (en)	2004-01-20
CA2200423A1 (en)	1997-09-26
EP1162264A2 (de)	2001-12-12
ES2123482T3 (es)	2002-11-01
DE69709561T2 (de)	2002-08-29
CA2200423C (en)	2006-12-19
ES2123482T1 (es)	1999-01-16
EP0798378B1 (de)	2002-01-16
HUP9700636A2 (hu)	1998-04-28
HK1001978A1 (en)	1998-07-24
JPH104986A (ja)	1998-01-13

Publication	Publication Date	Title
ATE212055T1 (de)	2002-02-15	Östrogen-rezeptor
HN1997000040A (es)	1997-06-05	Sal mesilatotrihidroto de 5-2-4-1,2 -benzoisotiazol -3 il 1- piperazinil etil -6 - cloro 13 dihidro 2h indol 2-ona.
ID24583A (id)	2000-07-27	Turunan-turunan 1,2,3,4-tetrahidronaftalena tersubstitusi
EE9800171A (et)	1998-12-15	3-pürasoolkarboksamiidi derivaadid, mis omavad afiinsust kannabinoidretseptori suhtes
NL1008164A1 (nl)	1998-08-03	Ruimer.
DE69708120T2 (de)	2002-07-25	Laser-absorbierende, lichtbleichbare zusammensetzungen
BR9706717B1 (pt)	2009-01-13	mecanismo de distribuição.
TR199700090A2 (tr)	1997-08-21	Yeni heteroaril-oksazolidinonlar.
DZ2769A1 (fr)	2003-12-01	Composés tricycliques substitués.
DE69824719D1 (de)	2004-07-29	Cytokinähnlicher faktor-7 aus säugetieren
CY1107339T1 (el)	2012-12-19	Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης
IT1303546B1 (it)	2000-11-14	Cerniera lampo.
ZA992773B (en)	2002-07-16	Substituted tricyclics.
NO991948D0 (no)	1999-04-23	Multi-funksjonelle, chimeriske hematopoietiske reseptorantagonister
DE69221823T2 (de)	1998-01-02	Oxytocin-Rezeptor, dafür kodierende DNS
TR199501389A2 (tr)	1996-07-21	Adesyon reseptörü antagonistleri (karsitlari).
NO990666D0 (no)	1999-02-12	FremgangsmÕte for diversitets-kombinering, samt mottaker
DE69725459D1 (de)	2003-11-13	Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
ZA988637B (en)	2000-03-22	Methods for regulating trkA expression.
ATE310732T1 (de)	2005-12-15	7-phenyl-1,4-diazepanderivate als neurokininrezeptorantagonisten
WO2000037634A3 (en)	2001-01-18	Novel polypeptides and nucleic acids encoding same
ATE231848T1 (de)	2003-02-15	Substituierte 2-benzoyl-cyclohexan-1,3-dione
TR199601082A3 (tr)	1999-10-21	Entegrin reseptör antagonistleri.
DE19882714T1 (de)	2000-08-24	Stufenloser, Industionsgesteuerter Spannungsregler
ES1033403Y (es)	1997-01-01	Encendedor solar ecologico perfeccionado.